Access event photos here.

Prominent names from the field are speaking at the event:

Wadhwani Research Centre for Bioengineering (WRCB) was set up to be a world-class translational research centre in bioengineering at the Indian Institute of Technology, Bombay (IITB). WRCB supports faculty members across various departments of IITB in undertaking breakthrough interdisciplinary translational research. The projects carried out by the faculty members associated with WRCB have resulted in several patents and spin-off companies in diverse areas ranging from diagnostics to drug discovery.

Currently in its 7^th year, the centre was established through a generous donation by Dr. Romesh Wadhwani - a successful serial entrepreneur and a signatory to the ‘giving pledge’. Dr. Wadhwani envisioned WRCB as a catalyst to enable India to be at the forefront of the bioengineering industry. The four core focus areas of the centre are Diagnostics, Therapeutics, MedTech, and Synthetic Biology

The projects carried out by the faculty members associated with WRCB have resulted in 70+ publications, 50+ patent applications, and 4 spinoff companies. Recent spin-offs from WRCB include ImmunoACT- a CAR-T cell therapy company, Clarity Biosystems – a company specializing in a highly accurate new-born screening platform, Metflux - using proprietary platform to accelerate physiological & therapeutic research and bring personalized digital solutions for healthcare and Algorithmic Biologics, whose technology greatly simplifies large scale pooled molecular testing which is useful in situations such as the covid pandemic and other applications that warrant large numbers of samples to be tested. In addition to these recent spin-offs, the centre has an active year-to-year commercialization pipeline.